Commerzbank Aktiengesellschaft’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
Sell
-42,000
Closed -$86K 101
2020
Q1
$86K Buy
+42,000
New +$3.58M ﹤0.01% 419
2019
Q3
Sell
-30,600
Closed -$10K 833
2019
Q2
$10K Buy
+30,600
New +$2.41M ﹤0.01% 1039

Other funds holding ABBV

Commerzbank Aktiengesellschaft's ABBV Position: Q1 2026 in Review

Commerzbank Aktiengesellschaft reduced its AbbVie (ABBV) stake by 9.3% in Q1 2026, selling an estimated $1.63M and leaving 72,061 shares worth $15.7M. The position accounts for 0.33% of the portfolio, ranked #45.

Commerzbank Aktiengesellschaft first reported a position in ABBV in Q2 2013 and has held it in 40 quarters since. The position peaked at $62.6M in Q2 2013. 4,077 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

  • Commerzbank Aktiengesellschaft held 72,061 shares of AbbVie worth $15.7M as of Q1 2026.
  • Commerzbank Aktiengesellschaft sold 7,351 AbbVie shares in Q1 2026, an estimated $1.63M.
  • AbbVie made up 0.33% of Commerzbank Aktiengesellschaft's portfolio in Q1 2026, its #45 holding.
  • Commerzbank Aktiengesellschaft first reported a position in AbbVie in Q2 2013 and has held it in 40 quarters since.
  • Commerzbank Aktiengesellschaft's AbbVie position peaked at $62.6M in Q2 2013.
  • 4,077 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Commerzbank Aktiengesellschaft's 13F filing for Q1 2026, filed 7 May 2026.